2026 APFED HOPE Grant
Forecasted
The 2026 APFED HOPE Grant funds early-stage research advancing diagnostics or therapies for eosinophil-associated diseases, excluding nasal polyposis, through support from the American Partnership for Eosinophilic Disorders.
Funder: American Partnership for Eosinophilic Disorders
Due Dates (Anticipated): April 2027 (Full application submission deadline, projected)
Funding Amounts: Up to $100,000 total ($50,000/year for 2 years) plus a $1,000 travel grant
Summary: Supports innovative research projects advancing diagnostics or therapeutics for eosinophil-associated diseases (excluding nasal polyposis).
Key Information: No indirect costs or PI salary allowed; must be employed at a U.S. institution.
Description
This program supports early-stage, innovative research projects focused on eosinophil-associated diseases (EADs), with the goal of generating preliminary data that can lead to future external funding. The grant emphasizes projects aimed at improving diagnostics or therapeutics for EADs, but explicitly excludes research on nasal polyposis. Funding is intended to help researchers initiate impactful studies that align with the mission of the American Partnership for Eosinophilic Disorders (APFED). The program encourages applications from investigators across a variety of disciplines.
